Skip to main content
SpringerLink
Log in

Campylobacter jejuni / coli und Guillain -Barré-Syndrom

  • Chapter
Infektiologie Aktuelle Aspekte

Part of the book series: Infektiologie Aktuelle Aspekte ((INFEKTIOLOGIE))

Zusammenfassung

Der darmpathogene Erreger Campylobaeter jejuni/coli hat seit seiner Erstbeobachtung „als Vibrionen im Darmkanal von Säuglingen“ mit Cholera infantis durch Theodor Escherich im Jahr 18861 im Bewusstsein der Medizin eine wechselvolle Geschichte erlebt. Bis zum 1. Weltkrieg als „spiralförmige Bakterien bei choleraähnlichen Durchfällen“ Gegenstand zahlreicher Publikationen, blieb der Erreger fast ein Jahrhundert in der Humanmedizin weitgehend unbeachtet, bis er von J.P. Butzler 1972 als wichtige Ursache der fieberhaften Diarrhöe im Kindesalter erkannt und von M. B. Skirrow 1974 in seiner Publikation „Campylobaeter enteritis: A new disease“ einer breiten Öffentlichkeit bekanntgemacht wurde (Lit. bei 2) Inzwischen zählt Campylobaeter jejuni/coli als einer der „Emerging Pathogens“ zu den häufigsten bakteriellen Durchfallerregern weltweit. In einigen Industrieländer übertrifft die Häufigkeit von Campylobaeter jejuni/coli bereits die der Salmonellosen, so wurden kürzlich bei einer prospektiven Studie in Schweden aus Stuhlproben von Patienten mit Diarrhöe in 13% Campylobaeter jejuni/ coli aber nur in 7% Salmonellen isoliert3.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Escherich T: Über das Vorkommen von Vibrionen im Darmkanal und den Stuhlgängen der Säuglinge. Münch Med Wochenschr 1886;33:815–817 and 833-835.

    Google Scholar 

  2. Kist M: Wer entdeckte Campylobacter jejuni/coli. Zbl Bakt Hyg 1986; A 261: 177–186.

    CAS  Google Scholar 

  3. Svenungsson B, Lagergren A, Ekwall E, Evengard B, Hedlund KO, Karnell A, Lofdahl S, Svensson L, Weintraub A: Enteropathogens in adult patients with diarrhea and healthy control subjects: a l-year prospective study in a Swedish clinic for infectious diseases. Clin Infect Dis 2000;30:770–778.

    Article  PubMed  CAS  Google Scholar 

  4. Robert-Koch-Institut: Jahresbericht 1998. Teil 1: Darminfektionen (Gastroenteritiden). Epidemiol Bull 1999;15/99:99–107

    Google Scholar 

  5. Skirrow MB, Blaser MJ: Campylobaeter jejuni; in Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL (eds): Infections of the Gastrointestinal Tract. New York, Raven Press, 1995, pp 825–248.

    Google Scholar 

  6. Blaser MJ, Parsons RB, Wang WL: Acute colitis caused by Campylobaeter fetus ss. jejuni. Gastroenterology 1980;78:448–453.

    PubMed  CAS  Google Scholar 

  7. Skirrow MB, Jones DM, Sutcliffe E, Benjamin J: Campylobaeter bacteraemia in England and Wales, 1981-91. Epidemiol Infect 1993; 110:567–573.

    Article  PubMed  CAS  Google Scholar 

  8. Meyer A, Stallmach T, Goldenberger D, Altwegg M: Lethal maternal sepsis caused by Campylobaeter jejuni: pathogen preserved in placenta and identified by molecular methods. Mod Pathol 1997; 10: 1253–1256.

    PubMed  CAS  Google Scholar 

  9. Peterson MC: Rheumatic manifestations of Campylobacter jejuni and C. fetus infections in adults. Scand J Rheumatol 1994;23: 167–170.

    Article  PubMed  CAS  Google Scholar 

  10. Keat A, Rowe I: Reiter’s syndrome and associated arthritides. Rheum Dis Clin North Am 1991;17:25–42.

    PubMed  CAS  Google Scholar 

  11. Guillain, G., Barré, J. A., and Strohl, A: Sur un syndrome de radiculo-néurite avec hyperalbuminose du liquide céphalorachidien sans réaction cellulaire. Remarques sur les characteres cliniques et graphiques des réflexes tentineux. Bull Soc Med Hop de Paris 1916; 40:1462–1470.

    Google Scholar 

  12. Hughes RA, Rees JH: Clinical and epidemiologic features of Guillain-Barre syndrome. J Infect Dis 1997;176 (Suppl. 2):S92–S98.

    Article  PubMed  Google Scholar 

  13. McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, Wu HS, Zhaori G, Liu Y, Jou LP: Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333–342.

    Article  PubMed  CAS  Google Scholar 

  14. Hughes RA, Hadden RD, Gregson NA, Smith KJ: Pathogenesis of Guillain-Barre syndrome. J Neuroimmunol 1999;100:74–97.

    Article  PubMed  CAS  Google Scholar 

  15. Allos BM: Association between Campylobaeter infection and Guillain-Barré syndrome. J Infect Dis 1997; 176 (Suppl. 2):S125–S128

    Article  PubMed  Google Scholar 

  16. Jacobs BC, Rothbarth PH, van der Meche FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA: The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 1998;51:1110–1115.

    Article  PubMed  CAS  Google Scholar 

  17. Ropper AH: Campylobacter diarrhea and Guillain-Barre syndrome. Arch Neurol 1988;45:655–656.

    Article  PubMed  CAS  Google Scholar 

  18. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM: Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and antiglycolipid antibodies. Brain 1995;118:597–605.

    Article  PubMed  Google Scholar 

  19. Mishu B, Blaser MJ: Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin Infect Dis 1993;17:104–108.

    Article  PubMed  CAS  Google Scholar 

  20. McCarthy N, Andersson Y, Jormanainen V, Gustavsson O, Giesecke J: The risk of Guillain-Barre syndrome following infection with Campylobacter jejuni. Epidemiol Infect 1999;122: 15–17.

    Article  PubMed  CAS  Google Scholar 

  21. Kuroki S, Saida T, Nukina M, Haruta T, Yoshioka M, Kobayashi Y, Nakanishi H: Campylobaeter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues. Ann Neurol 1993;33:243–247.

    Article  PubMed  CAS  Google Scholar 

  22. Lior H, Woodward DL, Edgar JA, Laroche LJ, Gill P: Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors. J Clin Microbiol 1982;15:761–768.

    Google Scholar 

  23. Penner JL, Hennessy JN: Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J Clin Microbiol 1980;12:732–737.

    PubMed  CAS  Google Scholar 

  24. Rees JH, Soudain SE, Gregson NA, Hughes RA: Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333: 1374–1379.

    Article  PubMed  CAS  Google Scholar 

  25. Goddard EA, Lastovica AJ, Argent AC: Campylobacter 0:41 isolation in Guillain-Barre syndrome. Arch Dis Child 1997;76:526–528.

    Article  PubMed  CAS  Google Scholar 

  26. Wassenaar TM, Fry BN, Lastovica AJ, Wagenaar JA, Coloe PJ, Duim B: Genetic characterization of Campylobacter jejuni 0:41 isolates in relation with Guillain-Barré syndrome. J Clin Microbiol 2000;38:874–876.

    PubMed  CAS  Google Scholar 

  27. Endtz HP, Ang CW, van Den Braak N, Duim B, Rigter A, Price LJ, Woodward DL, Rodgers FG, Johnson WM, Wagenaar JA, Jacobs BC, Verbrugh HA, van Belkum A: Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes. J Clin Microbiol 2000;38:2297–2301.

    PubMed  CAS  Google Scholar 

  28. Yuki N, Sato S, Itoh T, Miyatake T: HLA-B35 and acute axonal polyneuropathy following Campylobacter jejuni infection. Neurology 1991;41:1561–1563

    Google Scholar 

  29. Rees JH, Vaughan RW, Kondeatis E, Hughes AC: HLA-class II alleles in Guillain-Barre syndrome and Miller Fisher syndrome and their association with preceding Campylobbacter jejuni infection. J Neuroimmunol 1995;62:53–57

    Article  PubMed  CAS  Google Scholar 

  30. Ma H, Nishimura M, Mine H, et al: HLA-and T-cell receptor gene polymorphisms in Guillain-Barré syndrome. Neurology 1998; 51:379–384

    Article  PubMed  CAS  Google Scholar 

  31. Yuki N, Sato S, Fujimoto S, Yamada S, Tsujino Y, Kinoshita A, Itoh T: Serotype of Campylobacter jejuni, HLA, and the Guillain-Barre syndrome. Muscle Nerve 1992;15:968–969

    Article  PubMed  CAS  Google Scholar 

  32. Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meche FG: Campylobacter jejuni infections and anti-GMI antibodies in Guillain-Barre syndrome. Ann Neurol 1996;40:181–187.

    Article  PubMed  CAS  Google Scholar 

  33. Jacobs BC, Hazenberg MP, van Doorn PA, Endtz HP, van der Meche FG: Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barre or Miller Fisher syndrome. J Infect Dis 1997;175:729–733.

    Article  PubMed  CAS  Google Scholar 

  34. Gregson NA, Rees JH, Hughes RA: Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS). J Neuroimmunol 1997;73:28–36.

    Article  PubMed  CAS  Google Scholar 

  35. Rees JH, Gregson NA, Hughes RA: Anti-ganglioside GMI antibodies in Guillain-Barre syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809–816.

    Article  PubMed  CAS  Google Scholar 

  36. Schwerer B, Neisser A, Bernheimer H: Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection. Infect Immun 1999;67:2414–2420.

    PubMed  CAS  Google Scholar 

  37. Koga M, Yuki N, Takahashi M, Saito K, Hirata K: Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barre and Fisher’s syndromes. J Neuroimmunol 1998;81:138–143.

    Article  PubMed  CAS  Google Scholar 

  38. Yuki N, Tagawa Y, Irie F, Hirabayashi Y, Handa S: Close association of Guillain-Barre syndrome with antibodies to minor monosialogangliosides GM1b and GM1 alpha. J Neuroimmunol 1997;74:30-34.

    Google Scholar 

  39. Yuki N, Ang CW, Koga M, Jacobs BC, van Doorn PA, Hirata K, van der Meche FG: Clinical features and response to treatment in Guillain-Barre syndrome associated with antibodies to GMlb ganglioside. Ann Neurol 2000;47:314–321.

    Article  PubMed  CAS  Google Scholar 

  40. Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I: Guillain-Barre syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Brain 2000;123: 116–124.

    Article  PubMed  Google Scholar 

  41. Ang CW, Yuki N, Jacobs BC, Koga M, van Doorn PA, Schmitz PI, van der Meche FG: Rapidly progressive, predominantly motor Guillain-Barre syndrome with anti-Ga1NAc-GD1a antibodies. Neurology 1999;53:2122–2127.

    Article  PubMed  CAS  Google Scholar 

  42. O’Leary CP, Veitch J, Durward WF, Thomas AM, Rees JH, Willison HJ: Acute oropharyngeal palsy is associated with antibodies to GQ1 band GT1a gangliosides. J Neurol Neurosurg Psychiatry 1996;61:649–651.

    Article  CAS  Google Scholar 

  43. Koga M, Yuki N, Ariga T, Morimatsu M, Hirata K: Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barre syndrome? J Neuroimmunol 1998;86:74–79.

    Article  PubMed  CAS  Google Scholar 

  44. Preston A, Mandrell RE, Gibson BW, Apicella MA: The lipooligosaccharides of pathogenic gram-negative bacteria. Crit Rev Microbiol 1996;22:139–180.

    Article  PubMed  CAS  Google Scholar 

  45. Karlyshev AV, Linton D, Gregson NA, Lastovica AJ, Wren BW: Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity. Mol Microbiol 2000;35:529–541.

    Article  PubMed  CAS  Google Scholar 

  46. Linton D, Gilbert M, Hitchen PG, Deli A, Morris HR, Wakarchuk WW, Gregson NA, Wren BW: Phase variation of a beta-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipooligosaccharide of Campylobacter jejuni. Mol Microbiol 2000;37:501–514.

    Article  PubMed  CAS  Google Scholar 

  47. Linton D, Karlyshev AV, Hitchen PG, Morris HR, Deli A, Gregson NA, Wren BW: Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide. Mol Microbiol 2000;35:1120–1134.

    Article  PubMed  CAS  Google Scholar 

  48. Wood AC, Oldfield NJ, O’Dwyer CA, Ketley JM: Cloning, mutation and distribution of a putative lipopolysaccharide biosynthesis locus in Campylobacter jejuni. Microbiology 1999;145:379–388.

    Article  PubMed  CAS  Google Scholar 

  49. Fry BN, Korolik V, ten Brinke JA, Pennings MT, Zalm R, Teunis BJ, Coloe PJ, van der Zeijst BA: The lipopolysaccharide biosynthesis locus of Campylobacter jejuni 81116. Microbiology 1998; 144:2049–2061.

    Article  PubMed  CAS  Google Scholar 

  50. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, Chillingworth T, Davies RM, Feltweil T, Holroyd S, Jagels K, Karlyshev AV, Moule S, Pallen MJ, Penn CW, Quail MA, Rajandream MA, Rutherford KM, van Vliet AH, Whitehead S, Barrell BG: The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 2000;403:665–668.

    Article  PubMed  CAS  Google Scholar 

  51. Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K, Handa S, Miyatake T: A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771–1775.

    Article  PubMed  CAS  Google Scholar 

  52. Yuki N, Handa S, Taki T, Kasama T, Takahashi M, Saito K: Cross-reactive antigen between nervous tissue and a bacterium elicits Gui1lain-Barre-Syndrome: molecular mimicry between ganglisoide GMI and lipopolysaccharide from Penner’s serotype 19 of Campytobacter jejuni. Biomed Research 1992;13:451–453.

    CAS  Google Scholar 

  53. Aspinall GO, Fujimoto S, McDonald AG, Pang H, Kurjanczyk LA, Penner JL: Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barre syndrome patients mimic human gangliosides in structure. Infect Immun 1994;62:2122–2125.

    PubMed  CAS  Google Scholar 

  54. Moran AP, Prendergast MM, Appelmelk BJ: Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol Med Microbiol 1996; 16: 105–115.

    Article  PubMed  CAS  Google Scholar 

  55. Prendergast MM, Willison HJ, Moran AP: Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barre syndrome. Infect Immun 1999;67:3698–3701.

    PubMed  CAS  Google Scholar 

  56. Nachamkin I, Ung H, Moran AP, Yoo D, Prendergast MM, Nicholson MA, Sheikh K, Ho T, Asbury AK, McKbann GM, Griffin JW: Ganglioside GM1 mimicry in Campytobacter strains from sporadic infections in the United States. J Infect Dis 1999;179: 1183–1189.

    Article  PubMed  CAS  Google Scholar 

  57. Sheikh KA, Ho TW, Nachamkin I, Li CY, Cornblath DR, Asbury AK, Griffin JW, McKhann GM: Molecular mimicry in Guillain-Barre syndrome. Ann N Y Acad Sci 1998;845:307–321.

    Article  PubMed  CAS  Google Scholar 

  58. Griffin JW, Li CY, Macko C, Ho TW, Hsieh ST, Xue P, Wang FA, Cornblath DR, McKhann GM, Asbury AK: Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barre syndrome. J Neurocytol 1996;25:33–51.

    Article  PubMed  CAS  Google Scholar 

  59. Hafer-Macko C, Hsieh ST, Li CY, Ho T W, Sheikh K, Cornblath DR, McKbann GM, Asbury AK, Griffin JW: Acute motor axon al neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996;40:635–644.

    Article  PubMed  CAS  Google Scholar 

  60. Takigawa T, Yasuda H, Kikkawa R, Shigeta Y, Saida T, Kitasato H: Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436–442.

    Google Scholar 

  61. Sheikh KA, Nachamkin I, Ho TW, Willison HJ, Veitch J, Ung H, Nicholson M, Li CY, Wu HS, Shen BQ, Cornblath DR, Asbury AK, McKbann GM, Griffin JW: Campylobacter jejuni lipopolysaccharides in Guillain-Barre syndrome: molecular mimicry and host susceptibility. Neurology 1998;51:371–378.

    Article  PubMed  CAS  Google Scholar 

  62. Jacobs BC, Endtz H, van der Meche FG, Hazenberg MP, Achtereekte HA, van Doorn PA: Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejulli from patients with Miller Fisher syndrome. Ann Neurol 1995;37:260–264.

    Article  PubMed  CAS  Google Scholar 

  63. Kornberg AJ, Pestronk A, Blume GM, Lopate G, Yue J, Habn A: Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes. Neurology 1996;47: 1317–1320.

    Article  PubMed  CAS  Google Scholar 

  64. Yuki N, Miyatake T: Guillain-Barre syndrome and Fisher’s syndrome following Campylobacter jejuni infection. Ann NY Acad Sci 1998;845:330–340.

    Article  PubMed  CAS  Google Scholar 

  65. Naehamkin I: Microbiologic approaches for studying Campylobacter species in patients with Guillain-Barré syndrome. J Infect Dis 1997;176 (Suppl. 2):S106–S114

    Article  Google Scholar 

Download references

Authors
  1. M. Kist
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Donauspital im SMZ-Ost, A-1220, Langobardenstraße 122, Wien, Austria

    Oskar Janata (Facharzt für Innere Medizin, Hygienebeauftragter Arzt) (Facharzt für Innere Medizin, Hygienebeauftragter Arzt)

  2. Med. Chem. Labordiagnostik u. Tropenmedizin, Abt. f. Infektiologie u. Tropenmedizin, Universitätsklinik für Innere Medizin, Ernst-Heydemannstraße 6, D-18057, Rostock, Germany

    Emil C. Reisinger (Facharzt für Innere Medizin) (Facharzt für Innere Medizin)

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Wien

About this chapter

Cite this chapter

Kist, M. (2001). Campylobacter jejuni / coli und Guillain -Barré-Syndrom. In: Janata, O., Reisinger, E.C. (eds) Infektiologie Aktuelle Aspekte. Infektiologie Aktuelle Aspekte. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6236-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6236-1_11

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83662-0

  • Online ISBN: 978-3-7091-6236-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation